BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 19286328)

  • 21. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy.
    Lee LJ; Sadow CA; Russell A; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):803-9. PubMed ID: 19286328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delineating the relationship between Point A prescription dose and pelvic lymph node doses in intracavitary high-dose-rate brachytherapy treatment of cervical cancer for use in low- and middle-income countries.
    Weaver J; Harmon G; Harkenrider MM; Surucu M; Wood A; Alite F; Small W
    Brachytherapy; 2018; 17(1):201-207. PubMed ID: 29066085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose to pelvic lymph nodes in image based high dose rate brachytherapy of carcinoma cervix.
    Rangarajan R; Subramanian S; Gopalakrishnan K; Jothi V; Krishnamurthy K
    Rep Pract Oncol Radiother; 2019; 24(1):80-85. PubMed ID: 30505237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the anatomical position of point B and the relationship between point B dose and the dose delivered to pelvic lymph nodes in CT-based high-dose-rate brachytherapy for uterine cervical cancer.
    Matsukawa H; Sasaki T; Hirayama R; Hirose TA; Fukunaga JI
    J Contemp Brachytherapy; 2019 Apr; 11(2):137-145. PubMed ID: 31139222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of image-guided adaptive brachytherapy to pelvic nodes treatment in locally advanced cervical cancer.
    Bacorro W; Dumas I; Levy A; Rivin Del Campo E; Canova CH; Felefly T; Huertas A; Marsolat F; Haie-Meder C; Chargari C; Mazeron R
    Brachytherapy; 2017; 16(2):366-372. PubMed ID: 28159552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.
    Small W; Mell LK; Anderson P; Creutzberg C; De Los Santos J; Gaffney D; Jhingran A; Portelance L; Schefter T; Iyer R; Varia M; Winter K; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):428-34. PubMed ID: 18037584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours.
    Viswanathan AN; Dimopoulos J; Kirisits C; Berger D; Pötter R
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):491-8. PubMed ID: 17331668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
    Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
    Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy.
    Taylor A; Rockall AG; Reznek RH; Powell ME
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1604-12. PubMed ID: 16198509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A three-dimensional definition of nodal spaces on the basis of CT images showing enlarged nodes for pelvic radiotherapy.
    Portaluri M; Bambace S; Perez C; Angone G
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1101-7. PubMed ID: 15913911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.
    Haie-Meder C; Pötter R; Van Limbergen E; Briot E; De Brabandere M; Dimopoulos J; Dumas I; Hellebust TP; Kirisits C; Lang S; Muschitz S; Nevinson J; Nulens A; Petrow P; Wachter-Gerstner N;
    Radiother Oncol; 2005 Mar; 74(3):235-45. PubMed ID: 15763303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation.
    Portelance L; Chao KS; Grigsby PW; Bennet H; Low D
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):261-6. PubMed ID: 11516876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.
    Nag S; Erickson B; Thomadsen B; Orton C; Demanes JD; Petereit D
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):201-11. PubMed ID: 10924990
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.